About Ascendis Pharma
Ascendis Pharma is a biopharmaceutical company whose work uses the TransCon platform to develop treatments in several therapeutic areas.
The company develops treatments in rare diseases and endocrinology. Its TransCon platform is designed to adapt the release of active substances and supports its research programmes. The corporate website distinguishes medicines, clinical trials and programmes that remain in development.
Official sources
- Ascendis Pharma: Patients. Science. Passion.
- Ascendis Pharma — implantations officielles, opérations commerciales France et Benelux
Information checked 10 November 2026
Logo sourceAssociated catalogue products
2 references
These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.
YORVIPATH 294 µg/0,98 ml S inj en stylo prérempli 2Stylo/0,98ml+30aig
CIP / EAN : 3400930288993
YORVIPATH 420 µg/1,4 ml S inj en stylo prérempli 2Stylo/1,4ml+30aig
CIP / EAN : 3400930289006
Your professional shop
Open the shop to sign in, view the terms available to your account and place your order.
Open the shop